Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in India / NCT07416864
Recruiting Not applicable

Enhancing Operational Efficiency in Eye Care Services

NCT07416864 · tracked via the Priya Life Science India tracker
Sponsor
Seva Canada Society
Phase
Not applicable
Started
2026-03-01
Last updated
2026-05-05

Condition(s) studied

Quality ImprovementAppointments and SchedulesOperations Research Workflow

Investigational drug(s) / intervention(s)

Health service Optimization

Health service Optimization: * Introduction of validated appointment checklist * Presence of single Point of Contact (POC) for patient transfer from Ward to OT to Ward * Standardize Discharge documentation protocol through EMR IP billing

Study summary

Pushpagiri Vitreo Retina Institute (PVRI) based in Secunderabad is a tertiary care eye hospital providing specialty eye care services since 2007. Over 15-20 preplanned surgical/clinical procedures are conducted for patients requiring care on a daily basis. They range from simple cataract surgeries or injections to detailed specialty surgeries including Vitreo-retina, glaucoma, pediatric eye care and muscular conditions of the eye. All procedures are elective procedures and are pre-planned. The current study aims to improve hospital efficiency and reduce the total appointment time for patients. The current study aims to reduce patient overall waiting time by 15-25% by introducing simple patient identification tools to help streamline all planned procedures.

Eligibility

Sex
ALL
Min age
—
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria: * All patients undergoing pre-planned elective procedures in the unit listed on appointment basis. * Eligibility: Enrolment criteria: any patient undergoing any planned procedure is included on daily basis Exclusion criteria: * Patients undergoing emergency procedures. * Data for patients whose procedures were cancelled/postponed * Any other patients undergoing procedures under the free eye camps

Primary outcome measure(s)

  • Patient appointment time — 6-8 months
    Reduction of overall Patient appointment time by 15-25%

Trial sites (1)

FacilityCityRegionStatus
Pushpagiri Vitreo Retina Institute Secunderabad Telangana Recruiting

More Seva Canada Society trials in India

Reducing Patient Waiting Time for Cataract Surgery Recruiting
Strengthening Community- to- Hospital Eye Care Pathways From Boko Eye Care Center in Rural Assam Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07416864 on ClinicalTrials.gov ↗ ← All trials in India